Nieman Jan 4
4 · QUAKER CHEMICAL CORP · Filed Mar 7, 2019
Insider Transaction Report
Form 4
Nieman Jan
VP & Managing Director - A/P
Transactions
- Tax Payment
Common Stock
2019-03-05$202.49/sh−466$94,360→ 4,187 total - Exercise/Conversion
Common Stock
2019-03-05$151.75/sh+614$93,175→ 4,653 total - Exercise/Conversion
Common Stock
2019-03-05$72.12/sh+1,213$87,482→ 4,671 total - Tax Payment
Common Stock
2019-03-05$202.49/sh−771$156,120→ 3,900 total - Exercise/Conversion
Common Stock
2019-03-05$134.60/sh+729$98,123→ 4,629 total - Tax Payment
Common Stock
2019-03-05$202.49/sh−590$119,469→ 4,039 total - Exercise/Conversion
Employee Stock Option (right to buy)
2019-03-05−1,213→ 0 totalExercise: $72.12Exp: 2023-02-23→ Common Stock (1,213 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2019-03-05−729→ 729 totalExercise: $134.60Exp: 2024-02-27→ Common Stock (729 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2019-03-05−614→ 1,227 totalExercise: $151.75Exp: 2025-02-26→ Common Stock (614 underlying)
Holdings
- 569(indirect: By 401(k))
Common Stock
Footnotes (3)
- [F1]The options for this grant vested in three annual installments: 1,213 shares on February 23, 2017; 1,213 shares on February 23, 2018; and 1,213 shares on February 23, 2019.
- [F2]The options for this grant vest in three annual installments: 730 shares on February 27, 2018; 729 shares on February 27, 2019; and 729 shares on February 27, 2020.
- [F3]The options for this grant vest in three annual installments: 614 shares on February 26, 2019; 614 shares on February 26, 2020; and 613 shares on February 26, 2021.